AYMROXA
LIVE

Serial Number

98747397

Owner

AMGEN INC.

Attorney

Elsa D. Lemoine

Filing Date

Sep 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AYMROXA Trademark

Serial Number: 98747397

AYMROXA is a trademark filed by AMGEN INC. on September 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

AMGEN INC. (802 trademarks)

THOUSAND OAKS, CA 91320

Entity Type: 03

Trademark Details

Filing Date

September 12, 2024

Registration Date

Not Registered

Published for Opposition

July 22, 2025

Goods & Services

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of the gastrointestinal disorders; Pharmaceutical preparations for the treatment of dermatological diseases and disorders, skin conditions, alopecia, atopic dermatitis, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of asthma and other breathing disorders

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 18, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2025 TROA
ASSIGNED TO LIE
Apr 8, 2025 ALIE
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 18, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 18, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 14, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 14, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 14, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 12, 2024 NWOS
NEW APPLICATION ENTERED
Sep 12, 2024 NWAP